Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-17-009262
Filing Date
2017-05-15
Accepted
2017-05-15 16:46:23
Documents
54
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q sphs20170331_10q.htm 10-Q 1049281
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 13541
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 14741
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 8186
5 EXHIBIT 32.2 ex32-2.htm EX-32.2 8155
  Complete submission text file 0001437749-17-009262.txt   3991659

Data Files

Seq Description Document Type Size
6 EXHIBIT 101.INS sphs-20170331.xml EX-101.INS 846050
7 EXHIBIT 101.SCH sphs-20170331.xsd EX-101.SCH 37857
8 EXHIBIT 101.CAL sphs-20170331_cal.xml EX-101.CAL 27223
9 EXHIBIT 101.DEF sphs-20170331_def.xml EX-101.DEF 220965
10 EXHIBIT 101.LAB sphs-20170331_lab.xml EX-101.LAB 174076
11 EXHIBIT 101.PRE sphs-20170331_pre.xml EX-101.PRE 238303
Mailing Address 1258 PROSPECT STREET LA JOLLA CA 92037
Business Address 1258 PROSPECT STREET LA JOLLA CA 92037 858-777-1760
SOPHIRIS BIO INC. (Filer) CIK: 0001563855 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36054 | Film No.: 17845077
SIC: 2834 Pharmaceutical Preparations